Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy
about
Immune selection and within-host competition can structure the repertoire of variant surface antigens in Plasmodium falciparum--a mathematical modelAnalysis of IgG with specificity for variant surface antigens expressed by placental Plasmodium falciparum isolatesThe Structure of a Chondroitin Sulfate-binding Domain Important in Placental MalariaStructural Comparison of Two CSPG-Binding DBL Domains from the VAR2CSA Protein Important in Malaria during PregnancyPlasmodium falciparum infection significantly impairs placental cytokine profile in HIV infected Cameroonian women.HIV impairs opsonic phagocytic clearance of pregnancy-associated malaria parasites.Recrudescent Plasmodium berghei from pregnant mice displays enhanced binding to the placenta and induces protection in multigravidaTowards the rational design of a candidate vaccine against pregnancy associated malaria: conserved sequences of the DBL6epsilon domain of VAR2CSA.Kinetics of B cell responses to Plasmodium falciparum erythrocyte membrane protein 1 in Ghanaian women naturally exposed to malaria parasitesClinical malaria among pregnant women on combined insecticide treated nets (ITNs) and intermittent preventive treatment (IPTp) with sulphadoxine-pyrimethamine in Yaounde, Cameroon.Rapid acquisition of isolate-specific antibodies to chondroitin sulfate A-adherent plasmodium falciparum isolates in Ghanaian primigravidae.Immunohistological characterization of macrophage migration inhibitory factor expression in Plasmodium falciparum-infected placentas.Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes.The role of Plasmodium falciparum var genes in malaria in pregnancy.Effects of pregnancy and intensity of Plasmodium falciparum transmission on immunoglobulin G subclass responses to variant surface antigens.Resisting and tolerating P. falciparum in pregnancy under different malaria transmission intensitiesIFN-gamma and TNF associated with severe falciparum malaria infection in Saudi pregnant women.Advances and challenges in malaria vaccine development.High avidity antibodies to full-length VAR2CSA correlate with absence of placental malaria.Expression of variant surface antigens by Plasmodium falciparum parasites in the peripheral blood of clinically immune pregnant women indicates ongoing placental infection.Parity and placental infection affect antibody responses against Plasmodium falciparum during pregnancy.Chondroitin sulfate proteoglycan expression and binding of Plasmodium falciparum-infected erythrocytes in the human placenta during pregnancy.The antibody response of pregnant Cameroonian women to VAR2CSA ID1-ID2a, a small recombinant protein containing the CSA-binding sitePlasmodium falciparum-infected erythrocytes adhere both in the intervillous space and on the villous surface of human placenta by binding to the low-sulfated chondroitin sulfate proteoglycan receptor.How specific is Plasmodium falciparum adherence to chondroitin 4-sulfate?Protective Antibodies against Placental Malaria and Poor Outcomes during Pregnancy, BeninProspects and Pitfalls of Pregnancy-Associated Malaria Vaccination Based on the Natural Immune Response to Plasmodium falciparum VAR2CSA-Expressing Parasites.Identification of a Major Dimorphic Region in the Functionally Critical N-Terminal ID1 Domain of VAR2CSA.High levels of antibodies to multiple domains and strains of VAR2CSA correlate with the absence of placental malaria in Cameroonian women living in an area of high Plasmodium falciparum transmission.Developmental stage- and cell cycle number-dependent changes in characteristics of Plasmodium falciparum-infected erythrocyte adherence to placental chondroitin-4-sulfate proteoglycan.The immuno-epidemiology of pregnancy-associated Plasmodium falciparum malaria: a variant surface antigen-specific perspective.Malaria during Pregnancy.Decline of placental malaria in southern Ghana after the implementation of intermittent preventive treatment in pregnancyComparison of the specificity of antibodies to VAR2CSA in Cameroonian multigravidae with and without placental malaria: a retrospective case-control study.Epidemiology and Risk Analysis of Malaria among Pregnant Women.Antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to chondroitin sulfate A and to the C terminus of merozoite surface protein 1 correlate with reduced placental malaria in Cameroonian womenOverproduction, purification and crystallization of a chondroitin sulfate A-binding DBL domain from a Plasmodium falciparum var2csa-encoded PfEMP1 proteinInfluence of Intermittent Preventive Treatment on Antibodies to VAR2CSA in Pregnant Cameroonian WomenCytoadhesion of Plasmodium falciparum-infected erythrocytes and the infected placenta: a two-way pathway.
P2860
Q21562686-55B43002-1F8E-4758-9251-7A5E447AFFB9Q24792921-DD9AE646-6AD6-4275-9F28-F9B562F6A778Q27650818-9EB101FF-6AAE-4048-8718-87E8F7C2EB0EQ27657099-E735E742-357F-4B16-99B0-1E9AE3F8297DQ30940547-A039B985-056E-49AB-8405-43569F77EAA7Q33286064-7D263C7F-62A2-45C2-AAAC-2280D35676A5Q33450639-66281778-E4D4-4FD9-9C58-6FB9F7324A67Q33619319-E8A2AA5D-F54D-4674-9057-4DD1243C8377Q33630156-E485D451-9C67-42C0-BAE4-0FE12A548636Q33687284-D5B4C67C-A7EA-4691-8626-DE89AA71AD2EQ33769097-03AB6E5D-0A43-4147-8C0C-7A6A971DFDA8Q33788169-672F4304-AC27-4E2D-BFD0-645FD509F7FFQ33826049-8899B068-C585-4DEE-9A09-F598612FEE60Q33826076-E61B7934-6F6B-4201-A9BE-50445384010BQ33849067-681C6FB7-E3E7-464A-BF42-067ED39CA2FBQ33883435-DDD6D510-410B-48BA-B0E0-1897206B091DQ33910163-3E8B3158-03EB-4DED-A896-148A91B9F1ABQ34062601-8B2B43E6-9774-4540-884D-679AC2A779A0Q34145333-3C19D724-962B-469B-ACC7-9AA514CD2B8AQ34326742-F0E5A944-CC42-473D-9530-A00A3A55A8D9Q34715375-449A31B7-7F06-4292-9C14-8C27726E29F7Q34740303-D2E96EF6-12DF-429B-B1EF-9A1A1CDE7D16Q34934975-F3969B91-2196-4789-A8E7-C5CD85708F49Q35088554-8289057C-304B-4ADD-A752-38D52B74C752Q35098438-7514594E-3536-4E44-A662-37F3F3DADC17Q35156896-B924A6C0-4A52-4D66-B8CD-6F3FA08902D5Q35546075-F020B20F-176F-4451-BF6E-B5AEB4592C70Q35738477-14A2FC03-7A63-467A-93A7-A8A8181567E8Q35783076-9A141E5F-59C0-420E-BF68-8EDBF7C99ECFQ35867607-66308830-7036-4687-95F4-2540D32F2EB4Q35947173-B47D1360-0FAE-4293-8ACA-6911DC1029A3Q36072558-71337F93-C292-4680-8F00-FAAC6F5D8468Q36284603-9AF5346B-2E77-41BD-9617-656DA4B7B5E2Q36327851-3F5C1638-7013-4C5A-82F2-32F0C98C04B0Q36336978-869F1AA3-8A1E-4568-90B7-53874DCE0F00Q36348741-248D8D47-C678-4A72-904F-2C5C00B44142Q36576445-331B7E4C-2E41-479E-9BC8-437FDE8F5A26Q36640619-C3580C2A-5945-4B62-8673-98C1D02E325CQ36644516-30C729E5-90D3-4E1F-8BDB-29F75178EE85Q36679343-C5A66172-BF9B-4EDB-A17A-28E7BF7DBE65
P2860
Gravidity-dependent production of antibodies that inhibit binding of Plasmodium falciparum-infected erythrocytes to placental chondroitin sulfate proteoglycan during pregnancy
description
2001 nî lūn-bûn
@nan
2001 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Gravidity-dependent production ...... proteoglycan during pregnancy
@ast
Gravidity-dependent production ...... proteoglycan during pregnancy
@en
Gravidity-dependent production ...... proteoglycan during pregnancy
@nl
type
label
Gravidity-dependent production ...... proteoglycan during pregnancy
@ast
Gravidity-dependent production ...... proteoglycan during pregnancy
@en
Gravidity-dependent production ...... proteoglycan during pregnancy
@nl
prefLabel
Gravidity-dependent production ...... proteoglycan during pregnancy
@ast
Gravidity-dependent production ...... proteoglycan during pregnancy
@en
Gravidity-dependent production ...... proteoglycan during pregnancy
@nl
P2093
P2860
P1476
Gravidity-dependent production ...... proteoglycan during pregnancy
@en
P2093
C F Ockenhouse
D W Taylor
I O'Neil-Dunne
M Valiyaveettil
R Megnekou
P2860
P304
P356
10.1128/IAI.69.12.7487-7492.2001
P407
P577
2001-12-01T00:00:00Z